This past week, some of the world’s biggest R&D players doubled down on growth — Johnson & Johnson pledged $55B in U.S. investments, and AstraZeneca announced a new global R&D center in China — while others tightened their belts. Audi and Siemens both revealed significant job cuts, underscoring the shifting priorities in a fast-paced market…